1. Hermanussen M. Auxology: an update. Horm Res Paediatr 2010;74:153–64.
2. de Onis M, Wijnhoven TM, Onyango AW. Worldwide practices in child growth monitoring. J Pediatr 2004;144:461–5.
3. Ranke MB. Disease-specific standards in congenital syndromes. Horm Res 1996;45 Suppl 2:35–41.
4. Nagai T, Matsuo N, Kayanuma Y, Tonoki H, Fukushima Y, Ohashi H, et al. Standard growth curves for Japanese patients with Prader-Willi syndrome. Am J Med Genet 2000;95:130–4.
7. Isojima T, Yokoya S, Ito J, Horikawa R, Tanaka T. New reference growth charts for Japanese girls with Turner syndrome. Pediatr Int 2009;51:709–14.
9. Isojima T, Sakazume S, Hasegawa T, Ogata T, Nakanishi T, Nagai T, et al. Growth references for Japanese individuals with Noonan syndrome. Pediatr Res 2016;79:543–8.
11. Saenger P. Turner's syndrome. N Engl J Med 1996;335:1749–54.
12. Ranke MB, Saenger P. Turner's syndrome. Lancet 2001;358:309–14.
13. Sybert VP, McCauley E. Turner's syndrome. N Engl J Med 2004;351:1227–38.
14. Ranke MB, Grauer ML. Adult height in Turner syndrome: results of a multinational survey 1993. Horm Res 1994;42:90–4.
16. Rongen-Westerlaken C, Corel L, van den Broeck J, Massa G, Karlberg J, Albertsson-Wikland K, et al. Reference values for height, height velocity and weight in Turner's syndrome. Swedish Study Group for GH treatment. Acta Paediatr 1997;86:937–42.
17. Haeusler G, Schemper M, Frisch H, Blümel P, Schmitt K, Plöchl E. Spontaneous growth in Turner syndrome: evidence for a minor pubertal growth spurt. Eur J Pediatr 1992;151:283–7.
20. Suwa S. Standards for growth and growth velocity in Turner's syndrome. Acta Paediatr Jpn 1992;34:206–20.
21. Naeraa RW, Nielsen J. Standards for growth and final height in Turner's syndrome. Acta Paediatr Scand 1990;79:182–90.
22. Massa G, Vanderschueren-Lodeweyckx M, Malvaux P. Linear growth in patients with Turner syndrome: influence of spontaneous puberty and parental height. Eur J Pediatr 1990;149:246–50.
23. Ranke MB, Pflüger H, Rosendahl W, Stubbe P, Enders H, Bierich JR, et al. Turner syndrome: spontaneous growth in 150 cases and review of the literature. Eur J Pediatr 1983;141:81–8.
24. Tanaka T, Takano K, Hanew K, Nishi Y, Igarashi Y, Hirano T, et al. Registration system for growth hormone (GH) treatment with standardized immunoreactive GH values in Japan. Endocr J 1998;45:459–65.
25. Isojima T, Yokoya S, Ito J, Horikawa R, Tanaka T. Trends in age and anthropometric data at start of growth hormone treatment for girls with Turner syndrome in Japan. Endocr J 2008;55:1065–70.
26. Mochizuki T, Fujita K, Yokoya S. A questionnaire survey of the follow-up status in adult Turner women in Japan. Jpn J Pediatr 2010;114:43–7.
27. Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall B, Pierpont ME, et al. Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics 2010;126:746–59.
28. Nora JJ, Nora AH, Sinha AK, Spangler RD, Lubs HA. The Ullrich-Noonan syndrome (Turner phenotype). Am J Dis Child 1974;127:48–55.
29. Mendez HM, Opitz JM. Noonan syndrome: a review. Am J Med Genet 1985;21:493–506.
30. Noonan JA. Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease. Am J Dis Child 1968;116:373–80.
31. Allanson JE, Hall JG, Hughes HE, Preus M, Witt RD. Noonan syndrome: the changing phenotype. Am J Med Genet 1985;21:507–14.
32. Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 2001;29:465–8.
37. van der Burgt I, Berends E, Lommen E, van Beersum S, Hamel B, Mariman E. Clinical and molecular studies in a large Dutch family with Noonan syndrome. Am J Med Genet 1994;53:187–91.
38. Ranke MB, Heidemann P, Knupfer C, Enders H, Schmaltz AA, Bierich JR. Noonan syndrome: growth and clinical manifestations in 144 cases. Eur J Pediatr 1988;148:220–7.
39. Witt DR, Keena BA, Hall JG, Allanson JE. Growth curves for height in Noonan syndrome. Clin Genet 1986;30:150–3.
40. Malaquias AC, Brasil AS, Pereira AC, Arnhold IJ, Mendonca BB, Bertola DR, et al. Growth standards of patients with Noonan and Noonan-like syndromes with mutations in the RAS/MAPK pathway. Am J Med Genet A 2012;158A:2700–6.
41. Otten BJ, Noordam C. Growth in Noonan syndrome. Horm Res 2009;72 Suppl 2:31–5.
42. Noonan JA, Raaijmakers R, Hall BD. Adult height in Noonan syndrome. Am J Med Genet A 2003;123A:68–71.
43. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 1992;11:1305–19.
44. Wright EM, Royston P. A comparison of statistical methods for age-related reference intervals. J Royal Stat Soc A 1997;160:47–69.
45. Cole TJ. Fitting smoothed centile curves to reference data. J Royal Stat Soc A 1988;151:385–418.
47. Moon JS, Lee SY, Nam CM, Choi JM, Choe BK, Seo JW, et al. 2007 Korean National Growth Charts: review of developmental process and an outlook. Korean J Pediatr 2008;51:1–25.